Literature DB >> 8846174

Aneurysm formation in modified human umbilical vein grafts.

R Strobel1, A H Boontje, J J Van Den Dungen.   

Abstract

OBJECTIVES: Aneurysm formation in Human Umbilical Vein Grafts has been reported to be as high as 65% after 5 years. One of the causes might be the structure of the Biograft-wall and in 1985 a new method of processing the graft was begun. In Groningen this new improved Biograft has been used since late 1986.
DESIGN: Duplex scanning was used to examine the frequency of aneurysm formation in the new improved Biograft. MATERIALS: Sixty-nine patent Biografts have been examined in a period up to 6 years after implantation. MAIN
RESULTS: Aneurysms were found in only 17% of grafts although the frequency increased with time. Dilatation was common but may be due to a more elastic graft.
CONCLUSION: These findings justify the continued use of the new Biograft as a substitute for arterial femoropopliteal reconstructions.

Entities:  

Mesh:

Year:  1996        PMID: 8846174     DOI: 10.1016/s1078-5884(96)80173-0

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  3 in total

1.  Mechanical property characterization of electrospun recombinant human tropoelastin for vascular graft biomaterials.

Authors:  Kathryn A McKenna; Monica T Hinds; Rebecca C Sarao; Ping-Cheng Wu; Cheryl L Maslen; Robert W Glanville; Darcie Babcock; Kenton W Gregory
Journal:  Acta Biomater       Date:  2011-08-06       Impact factor: 8.947

2.  Structural and cellular characterization of electrospun recombinant human tropoelastin biomaterials.

Authors:  Kathryn A McKenna; Kenton W Gregory; Rebecca C Sarao; Cheryl L Maslen; Robert W Glanville; Monica T Hinds
Journal:  J Biomater Appl       Date:  2011-05-17       Impact factor: 2.646

3.  In Vivo Remodeling of Fibroblast-Derived Vascular Scaffolds Implanted for 6 Months in Rats.

Authors:  Maxime Y Tondreau; Véronique Laterreur; Karine Vallières; Robert Gauvin; Jean-Michel Bourget; Catherine Tremblay; Dan Lacroix; Lucie Germain; Jean Ruel; Francois A Auger
Journal:  Biomed Res Int       Date:  2016-11-24       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.